MeSH tree: C15.378.420.155
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) ...
Jul 9, 2026
0
4
Fewer serious complications. Fewer hospitalizations and blood transfusions. Better growth and development. And a markedly lower risk of death from the complications of sickle cell anemia.
Jun 3, 2026
0
6
Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new research published in Blood ...
Jun 2, 2026
0
6
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also may preserve fertility, according to results of a new study conducted ...
May 6, 2026
0
2
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10% of people with SCD in the US live in New York State, with the majority residing in New York City.
May 1, 2026
0
5
Scientists have long been puzzled by how maturing red blood cells manage to produce all the hemoglobin they need to carry oxygen to tissues, even after shedding the vital structures they need to produce it.
Apr 23, 2026
0
6
Individuals living with sickle cell disease in sub-Saharan Africa face disparities in treatment and health care access when compared with those in other low- and middle-income countries (LMICs) or high-income countries (HICs), ...
Apr 14, 2026
0
3
Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) in patients hospitalized in Boston, suggesting that tuberculosis disease may be significantly underdiagnosed ...
Apr 14, 2026
0
9
In season 1, episode 2 of the popular show "The Pitt," a Black woman with sickle cell disease arrives at the emergency department in acute pain, only to be initially dismissed as drug-seeking. "Unfortunately, this contemporary ...
Apr 13, 2026
0
3
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options. After research conducted as part of the multicenter ...
Apr 1, 2026
0
10
